Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compugen | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪516.98M | 88.3x | 0.84 | ILA 577.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lineage Cell Therapeutics | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪458.09M | -5.2x | -0.33 | ILA 216.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oramed Pharma | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪347.19M | 21.6x | 0.17 | ILA 867 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Batm | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪331.23M | -215.4x | 1.36 | ILA 81 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bonus Biogroup | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪127.30M | -2.6x | ILA 10.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
DNA Group TR | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪109.37M | 7.3x | 0.02 | ILA 88.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pluri Inc | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪108.39M | -1.3x | -0.05 | ILA 1,950 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioline Rx | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪95.99M | -1.3x | -0.02 | ILA 8 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enlivex | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪88.68M | -1.2x | -0.06 | ILA 411 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XTL Bio | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪80.28M | -17.6x | -0.67 | ILA 6.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Matricelf | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪62.14M | ILA 386.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Kadimastem Ltd | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪54.39M | -30.7x | -0.06 | ILA 1,297 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Evogene | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪40.48M | -0.4x | -0.11 | ILA 595.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nextage Therapeutics | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪25.14M | ILA 74.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Purple Biotech | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪23.05M | -0.3x | -0.01 | ILA 6.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merchavia | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪11.09M | -1.2x | -0.31 | ILA 66 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hadasit Bio | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪5.17M | -0.7x | -0.01 | ILA 46.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Univo Pharma | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪2.84M | ILA 93,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |